Finance

Beta
Lists
BIOV:SWX
BioVersys AG
CHF 26.80
+0.75%
(+0.20) 1D
Jun 9, 11:04:30 AM GMT+2  ·   CHF
All symbols
SymbolPriceChange% Change
Generating top insights for BIOV...
Open
CHF 26.40
High
CHF 26.80
Low
CHF 26.40
Mkt. cap
156.90M
Avg. vol.
1.30K
Volume
125.00
52-wk high
CHF 36.00
52-wk low
CHF 21.20
EPS
-CHF 3.73
Shares outstanding
5.85M
No. of employees
33
Open
CHF 26.40
High
CHF 26.80
Low
CHF 26.40
Mkt. cap
156.90M
Avg. vol.
1.30K
Volume
125.00
52-wk high
CHF 36.00
52-wk low
CHF 21.20
EPS
-CHF 3.73
Shares outstanding
5.85M
No. of employees
33
Analyst outlook
Analyst Ratings
Based on 2 analysts giving stock ratings to BIOV in the past 3 months
Buy
Buy
2
Hold
0
Sell
0
12 month forecast
Based on 2 Wall Street analysts offering 12 month price targets for BIOV in the last 3 months.
Highest
Current CHF 26.80
CHF 70.00 (+161.19%)
Average
CHF 55.00 (+105.22%)
Lowest
CHF 40.00 (+49.25%)
News stories
From sources across the web
About BioVersys AG
CEO-
Employees33
Founded2008
Headquarters-
SectorPharmaceutical industry
Previous reportsAll values in CHF
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in CHF
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Revenue
284.00K
284.00K
1.30M
1.30M
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
3.11M
3.11M
5.14M
5.14M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1.85M
1.85M
1.51M
1.51M
Operating expense
4.97M
4.97M
6.60M
6.60M
Total operating expenses
4.97M
4.97M
6.60M
6.60M
Operating income
-4.68M
-4.68M
-5.30M
-5.30M
Other non operating income
-531.00K
-531.00K
126.50K
126.50K
EBT including unusual items
-5.50M
-5.50M
-5.40M
-5.40M
EBT excluding unusual items
-5.50M
-5.50M
-5.40M
-5.40M
Income tax expense
-
-
8.00K
8.00K
Effective tax rate
-
-
-0.15%
-0.15%
Other operating expenses
-
-
-46.50K
-46.50K
Net income
-5.50M
-5.50M
-5.41M
-5.41M
Net profit margin
-1,938.38%
-1,938.38%
-415.04%
-415.04%
Earnings per share
-
-
-
-
Interest and investment income
21.00K
21.00K
1.50K
1.50K
Interest expense
-272.50K
-272.50K
-266.00K
-266.00K
Net interest expenses
-251.50K
-251.50K
-264.50K
-264.50K
Depreciation and amortization charges
-
-
-
-
EBITDA
-4.61M
-4.61M
-5.26M
-5.28M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more

Research

AI content may include mistakes. Learn more